Stempoint Capital’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-10,000
Closed -$10.8K – 74
2024
Q1
$10.8K Buy
+10,000
New +$2.26M ﹤0.01% 62

Other funds holding UTHR

Stempoint Capital's UTHR Position: Q3 2026 in Review

Stempoint Capital opened a new position in United Therapeutics (UTHR) in Q3 2026: 4,646 shares worth $2.52M. The stake represents 0.45% of the portfolio and ranks #58 among its holdings. This is a return to the name: Stempoint Capital previously reported a position in UTHR as recently as Q3 2025.

Stempoint Capital first reported a position in UTHR in Q3 2025 and has held it in 2 quarters since. The position peaked at $2.63M in Q3 2025. 848 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Stempoint Capital held 4,646 shares of United Therapeutics worth $2.52M as of Q3 2026.
  • United Therapeutics was a new Stempoint Capital position in Q3 2026.
  • United Therapeutics made up 0.45% of Stempoint Capital's portfolio in Q3 2026, its #58 holding.
  • Stempoint Capital first reported a position in United Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • Stempoint Capital's United Therapeutics position peaked at $2.63M in Q3 2025.
  • 848 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Stempoint Capital's 13F filing for Q3 2026, filed 16 Nov 2026.